Page 38 - Spring 2019 Journal
P. 38
Zvolensky MJ. Quality of life and risk of psychi- atric disorders among regular users of alcohol, nicotine, and cannabis: an analysis of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). J Psychiatr Res 2015;66- 67:135-41.
27. Marijuana use may be harmful to mental health. https://www.health.harvard.edu/mind-and-mood/ marijuana-use-may-be-harmful-to-mental-health- the-family-healthguide.
28. Patton GC, Coffey C, Carlin JB, et al. Cannabis use and mental health in young people: cohort study. BMJ 2002;325(7374):1195-8.
29. Bovasso GB. Cannabis abuse as a risk fac- tor for depressive symptoms. Am J Psychiatry 2001;158(12):2033-7.
30. Di Forti M, Marconi A, Carra E, et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry 2015;2(3):233-8.
31. Freeman TP, Winstock AR. Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychol Med 2015;45(15):3181-9.
32. A synopsis of the numerous studies supporting an [sic] causal relationship between marijuana use and the chronic psychotic disorder schizophrenia. http://momsstrong.org/wordpress/wp-content/ uploads/2016/01/Summary-of-literature-on- marijuana-and-psychosis.pdf.
33. Niemi-Pynttäri JA, Sund R, Putkonen H, Vorma H, Wahlbeck K, Pirkola SP. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases. J Clin Psychiatry 2013;74(1):e94-e99.
34. Lee KS, Conigrave KM, Clough AR, Dobbins TA, Jaragba MJ, Patton GC. Five-year longitudinal study of cannabis users in three remote Aboriginal communities in Arnhem Land, Northern Terri- tory, Australia. Drug Alcohol Rev 2009;28(6):623- 30.
35. Lee KS, Conigrave KM, Patton GC, Clough AR. Cannabis use in remote indigenous communities in Australia: endemic yet neglected. Med J Aust 2009;190(5):228-9.
36. Hall L. Cannabis takes toll on Aborigines. The Australian, Nov. 9, 2009.
37. Amen DG, Egan S, Meysami S, Raji CA, George N. Patterns of regional cerebral blood flow as a function of age throughout the lifespan. J Alz-heimer’s Dis 2018;65(4):1087-92.
38. Largest brain study of 62,454 scans identifies drivers of brain aging. Aug. 21, 2018. https://www. sciencedaily.com/releases/2018/08/180821112010. htm.
39. Orr C, Spechler P, Cao Z, et al. Grey matter vol- ume differences associated with extremely low levels of cannabis use in adolescence. J Neurosci 2019 Jan 14.
36
40. Silins E, Horwood LJ, Patton GC, et al. Young adult sequelae of adolescent cannabis use: an integrative analysis. Lancet Psychiatry 2014;1(4):286-93.
41. Shane’s story. http://momsstrong.org/our-stories/shanes-story/.
42. Andy’s story. http://momsstrong.org/our-stories/andys-story/.
43. How does marijuana affect blood pressure? https://www.leafscience.
com/2018/09/21/marijuana-affect-blood-pressure/.
44. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering
myocardial infarction by marijuana. Circulation 2001;103(23):2805-9.
45. Goyal H, Awad HH, Ghali JK. Role of cannabis in cardiovascular disorders.
J Thorac Dis 2017;9(7):2079-92.
46. Hartung B, Kauferstein S, Ritz-Timme S, Daldrup T. Sudden unexpected
death under acute influence of cannabis. Forensic Sci Int 2014;237:e11-e13. 47. Fox M. Did marijuana kill this young man? Doctors may never know for sure. Today, Aug. 17, 2017. https://www.today.com/health/family-believes-
marijuana-killed-their-healthy-son-t115183.
48. Nappe TM, Hoyte CO. Pediatric death due to myocarditis after exposure to
cannabis. Clin Pract Cases Emerg Med 2017;1(3):166-70.
49. Carroll L. Doctors debate whether baby died from marijuana overdose. NBC News, Nov. 17, 2017. https://www.nbcnews.com/health/kids-health/doctors-
debate-whether-baby-died-marijuana-overdose-n821801.
50. Press CA, Knupp KG, Chapman KE. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy Behav
2015;45:49-52.
51. Detyniecki K, Hirsch LJ. Cannabidiol for epilepsy: trying to see through the
haze. Lancet Neurol 2016;15(3):235-7.
52. Devinsky O, Cross H, Laux L, et al. Trial of cannabidiol for drug-resistant
seizures in the Dravet syndrome. New Engl J Med 2017;376(21):2011-20.
53. FDA approves first drug comprised of an active ingredient derived from mari- juana to treat rare, severe forms of epilepsy. https://www.fda.gov/NewsEvents/
Newsroom/PressAnnouncements/ucm611046.htm.
54. Ketogenic diet. https://www.epilepsy.com/learn/treating-seizures-and-
epilepsy/dietary-therapies/ketogenic-diet.
55. Murff HJ. Review: Weak evidence of benefits of cannabis for chronic neuro-
pathic pain: moderate to weak evidence of adverse effects. Ann Intern Med
2017;167(12):JC62.
56. Allan GM, Ramji J, Perry D, et al. Simplified guidelines for prescribing medi-
cal cannabinoids in primary care. Can Fam Physician 2018;64(2):111-20.
57. Stockings E, Campbell G, Hall WD, et al. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a system- atic review and meta-analysis of controlled and observational studies. Pain
2018;159(10):1932-54.
58. Current research on marijuana for pain is lacking. http://www.poppot.
org/2017/06/26/current-research-marijuana-pain-lacking/.
59. Campbell G, Hall WD, Peacock A, et al. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective
cohort study. Lancet Public Health 2018;3(7):e341-e350.
60. Ribeiro LI, Ind PW. Effect of cannabis smoking on lung function and respira-
tory symptoms: a structured literature review. NPJ Prim Care Respir Med
2016;26:16071.
61. Tashkin DP. The respiratory health benefits of quitting cannabis use. Eur
Respir J 2015;46(1):1-4.
62. Lacson JCA, Carroll JD, Tuazon E, Castelao EJ, Bernstein L, Cortessis VK.
Population-based case-control study of recreational drug use and testis cancer risk confirms association between marijuana use and non-seminoma risk. Cancer 2012;118(21):5374-83.
63. Ladin DA, Soliman E, Griffin L, Van Dross R. Preclinical and clinical assess- ment of cannabinoids as anti-cancer agents. Front Pharmacol 2016;7:361. 64. Efird JT, Friedman GD, Sidney S, et al. The risk for malignant primary adult-
onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol 2004; 68(1):57-69.
Wise Traditions SPRING 2019
